TC Biopharm (Holdings) Plc (TCBP)

NASDAQ: TCBP · IEX Real-Time Price · USD

1.530

-0.040 (-2.55%)

At close: Apr 26, 2024, 4:00 PM

1.570

+0.040 (2.61%)

After-hours: Apr 26, 2024, 7:36 PM EDT

TC Biopharm (Holdings) Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	Current	2023	2022	2021	2020	2019
Market Capitalization	2	1	3	-	-	-
Market Cap Growth	-	-65.69%	-	-	-	-
Enterprise Value	1	0	1	20	3	3
PE Ratio	-0.14	-0.14	-1.92	-	-	-
PS Ratio	-	-	0.66	-	-	-
PB Ratio	0.47	0.31	7.63	-	-	-
P/FCF Ratio	-0.08	-0.08	-0.16	-	-	-
P/OCF Ratio	-0.08	-0.08	-0.17	-	-	-
EV/Sales Ratio	-	-	0.13	7.62	1.15	0.72
EV/EBITDA Ratio	-0.03	-0.03	0.11	-1.43	-0.43	-0.43
EV/EBIT Ratio	-0.02	-0.02	0.13	-1.31	-0.36	-0.38
EV/FCF Ratio	-0.02	-0.02	-0.03	-2.31	-0.52	-0.29
Debt / Equity Ratio	0.67	0.67	8.39	-1.00	-0.90	-1.35
Debt / EBITDA Ratio	-0.29	-0.29	0.62	-1.58	-0.57	-0.60
Debt / FCF Ratio	-0.17	-0.17	-0.18	-2.55	-0.69	-0.40
Quick Ratio	0.52	0.52	0.52	0.12	0.25	0.58
Current Ratio	1.20	1.20	0.81	0.19	0.53	1.09
Asset Turnover	0	0	0.40	0.26	0.23	-
Interest Coverage	-83.26	-83.26	0.55	-3.36	-21.70	-24.03
Return on Equity (ROE)	-391.60%	-391.60%	16.20%	136.40%	185.40%	-
Return on Assets (ROA)	-58.40%	-58.40%	-13.60%	-177.60%	-62.70%	-
Return on Capital (ROIC)	-317.39%	-317.39%	-388.60%	-9649.88%	1968.76%	-738.57%
Earnings Yield	-475.16%	-715.39%	-51.95%	-	-	-
FCF Yield	-845.38%	-1290.45%	-612.14%	-	-	-
Buyback Yield / Dilution	-1015.02%	-799.07%	-24.02%	-	-	-
Total Shareholder Return	-1015.02%	-799.07%	-24.02%	-	-	-

Source: Financials are provided by Nasdaq Data Link and sourced from audited reports submitted to the Securities and Exchange Commission (SEC).